
Episode 505: A Breakthrough in Cholesterol Care With an Oral PCSK9 Inhibitor
Jul 21, 2026 - 23:30
Radio and PodcastLive Radio & Podcasts
Dr. Joel Kahn dives into a groundbreaking Phase 1 trial of Verve 102, a one-time intravenous gene-editing treatment that silences the PCSK9 gene to produce lasting LDL cholesterol reduction. Among 35 participants, the hi...
Episode 498: Do You Want a One and Done Cholesterol Infusion? The Long Road Ahead is an episode from Heart Doc VIP with Dr. Joel Kahn by Dr. Joel Kahn. Dr. Joel Kahn dives into a groundbreaking Phase 1 trial of Verve 102, a one-time intrave...
This episode belongs to Heart Doc VIP with Dr. Joel Kahn.
Use the player on this page to stream the episode online.
Published Jun 2, 2026, 31:14 long, audio available.